British scientists devise test to identify best AIDS vaccinesApril 27th, 2009 - 7:25 pm ICT by IANS
London, April 27 (IANS) British medical scientists have devised a test to identify the best potential AIDS vaccines, a newspaper reported Monday.
Early results suggest the test is able to detect not only whether a vaccine will generate a response from the body’s immune system, but also whether this response will actively fight HIV, the virus that causes AIDS, the Times reported.
The test, known as a viral inhibition assay, was devised by Imperial College London and the International AIDS Vaccine Initiative (IAVI).
It is being evaluated in a phase-one AIDS vaccine trial.
Scientists hope to use the test to check candidate vaccines, helping pick out the most promising for full trials while weeding out ineffective products, the newspaper said.
It said the project will be funded by a 40 million pound grant from Britain’s Department for International Development to IAVI.
- Human trials under way for new HIV vaccine - Jan 03, 2012
- THSTI,IAVI announce new HIV vaccine design program in India - Mar 04, 2011
- Cuba to test new AIDS vaccine - Mar 07, 2012
- Scientists re-educate body's immune system to repel HIV - Feb 03, 2011
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Scientists tame HIV by stripping it of cholesterol - Sep 29, 2011
- Monkey jab may open way for HIV vaccine - May 12, 2011
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine - Jul 09, 2010
- How interferon-induced genes launch antiviral defenses - Apr 11, 2011
- Novel vaccine that produces strong immunity against cocaine high created - Jan 05, 2011
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- Structure of immune molecule that counteracts HIV strains determined - Jun 02, 2010
Tags: aids, aids vaccine trial, aids vaccines, british scientists, candidate vaccines, hiv, immune system, imperial college london, inhibition, international aids vaccine, international aids vaccine initiative, medical scientists, phase one, virus, weeding